Trump officials push to onshore generic drug manufacturing
Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of health care. Confidential tips can be sent on Signal at danielp.100. WASHINGTON — Last week, pharmaceutical leaders filed into a meeting room in the Eisenhower Executive…
